Search Results 1131-1140 of 12723 for Livedo
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe this medicine is in the long ...
This week's episode of Tomorrow's Cure comes to you from the PlatforMed Conference, held in June 2025 in Minneapolis. The event brought together more than ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
"We are now more than two years out with working with this condition. And we have seen individuals who have had symptoms for a year and a half or.
About this study. The purpose of this study is to determine the lowest radiation dose that allows interpretation of chest CT scan.
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Larynx transplant ...
Health care professionals trained in many medical specialties work together as a team to ensure favorable outcomes from your heart transplant. Mayo Clinic has ...
Dr. Gregory Worrell shares how technological innovation is transforming the future of epilepsy care. Latest stories. Social isolation ...
About this study. The purpose of this study is to establish normal sonographic parameters in patients with an ileal pouch-anal anastomosis (IPAA) and normal ...
To assess the safety and tolerability of RBX2660 in subjects with recurrent CDI who have had prior recurrent CDI that was resolved with antibiotic treatment.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.